Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects

This study has been completed.

Study NCT00616655 Information provided by Sunovion

First Received: February 4, 2008 Last Updated: November 4, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2008
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: December 16, 2009